Insider Transactions in Q1 2023 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 02
2023
|
John C. Mc Kew Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
439
-1.63%
|
$1,317
$3.53 P/Share
|
Feb 01
2023
|
Richard J Hawkins Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
416
-0.06%
|
$1,248
$3.52 P/Share
|
Feb 01
2023
|
Richard J Hawkins Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+0.59%
|
$13,500
$3.52 P/Share
|
Feb 01
2023
|
David B Karpf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36
-0.43%
|
$108
$3.52 P/Share
|
Feb 01
2023
|
David B Karpf Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+10.72%
|
$3,000
$3.52 P/Share
|
Feb 01
2023
|
Lori D Lawley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.98%
|
$342
$3.52 P/Share
|
Feb 01
2023
|
Lori D Lawley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+7.92%
|
$3,000
$3.52 P/Share
|
Feb 01
2023
|
John C. Mc Kew Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.76%
|
$618
$3.52 P/Share
|
Feb 01
2023
|
John C. Mc Kew Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+6.87%
|
$6,000
$3.52 P/Share
|
Feb 01
2023
|
Bradley J Powers General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-2.03%
|
$393
$3.52 P/Share
|
Feb 01
2023
|
Bradley J Powers General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
900
+12.22%
|
$2,700
$3.52 P/Share
|
Feb 01
2023
|
Aaron Schuchart Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-1.9%
|
$312
$3.52 P/Share
|
Feb 01
2023
|
Aaron Schuchart Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+15.42%
|
$3,000
$3.52 P/Share
|